133 related articles for article (PubMed ID: 20598555)
21. Biological activity of bis-benzimidazole derivatives on DNA topoisomerase I and HeLa, MCF7 and A431 cells.
Alpan AS; Zencir S; Zupkó I; Coban G; Réthy B; Gunes HS; Topcu Z
J Enzyme Inhib Med Chem; 2009 Jun; 24(3):844-9. PubMed ID: 18951286
[TBL] [Abstract][Full Text] [Related]
22. 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit proliferation of estrogen receptor-negative breast cancer cells by activation of multiple pathways.
Vanderlaag K; Su Y; Frankel AE; Grage H; Smith R; Khan S; Safe S
Breast Cancer Res Treat; 2008 May; 109(2):273-83. PubMed ID: 17624585
[TBL] [Abstract][Full Text] [Related]
23. Organometallic cyclic polyphenols derived from 1,2-(alpha-keto tri or tetra methylene) ferrocene show strong antiproliferative activity on hormone-independent breast cancer cells.
Plazuk D; Top S; Vessières A; Plamont MA; Huché M; Zakrzewski J; Makal A; Woźniak K; Jaouen G
Dalton Trans; 2010 Aug; 39(32):7444-50. PubMed ID: 20614088
[TBL] [Abstract][Full Text] [Related]
24. Antiestrogenically active 1,1,2-tris(4-hydroxyphenyl)alkenes without basic side chain: synthesis and biological activity.
Lubczyk V; Bachmann H; Gust R
J Med Chem; 2003 Apr; 46(8):1484-91. PubMed ID: 12672249
[TBL] [Abstract][Full Text] [Related]
25. Synthesis of 2-aryl-4-(benzimidazol-2-yl)-1,2-dihydro[1,2,4]triazino-[4,5-a]benzimidazol-1-one derivatives with preferential cytotoxicity against carcinoma cell lines.
Stýskala J; Stýskalová L; Slouka J; Hajdúch M
Eur J Med Chem; 2008 Mar; 43(3):449-55. PubMed ID: 18272255
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and cytotoxicity evaluation of some benzimidazole-4,7-diones as bioreductive anticancer agents.
Gellis A; Kovacic H; Boufatah N; Vanelle P
Eur J Med Chem; 2008 Sep; 43(9):1858-64. PubMed ID: 18222567
[TBL] [Abstract][Full Text] [Related]
27. Stimulatory effect of genistein and apigenin on the growth of breast cancer cells correlates with their ability to activate ER alpha.
Seo HS; DeNardo DG; Jacquot Y; Laïos I; Vidal DS; Zambrana CR; Leclercq G; Brown PH
Breast Cancer Res Treat; 2006 Sep; 99(2):121-34. PubMed ID: 16541309
[TBL] [Abstract][Full Text] [Related]
28. 2-phenylindole sulfamates: inhibitors of steroid sulfatase with antiproliferative activity in MCF-7 breast cancer cells.
Walter G; Liebl R; von Angerer E
J Steroid Biochem Mol Biol; 2004 Apr; 88(4-5):409-20. PubMed ID: 15145451
[TBL] [Abstract][Full Text] [Related]
29. Concentration-dependent mitogenic and antiproliferative actions of 2-methoxyestradiol in estrogen receptor-positive human breast cancer cells.
Liu ZJ; Zhu BT
J Steroid Biochem Mol Biol; 2004 Mar; 88(3):265-75. PubMed ID: 15120420
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of novel isatin-thiazoline and isatin-benzimidazole conjugates as anti-breast cancer agents.
Taher AT; Khalil NA; Ahmed EM
Arch Pharm Res; 2011 Oct; 34(10):1615-21. PubMed ID: 22076761
[TBL] [Abstract][Full Text] [Related]
31. Cytotoxicity and DNA interactions of some platinum(II) complexes with substituted benzimidazole ligands.
Ozçelik AB; Utku S; Gümüş F; Keskin AÇ; Açık L; Yılmaz S; Ozgüngör A
J Enzyme Inhib Med Chem; 2012 Jun; 27(3):413-8. PubMed ID: 22299582
[TBL] [Abstract][Full Text] [Related]
32. Detection of an elevated HER2 expression in MCF-7 breast cancer cells overexpressing estrogen receptor beta1.
Lattrich C; Juhasz-Boess I; Ortmann O; Treeck O
Oncol Rep; 2008 Mar; 19(3):811-7. PubMed ID: 18288420
[TBL] [Abstract][Full Text] [Related]
33. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
Swami S; Krishnan AV; Feldman D
Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
[TBL] [Abstract][Full Text] [Related]
34. Transactivation of ERalpha by Rosiglitazone induces proliferation in breast cancer cells.
Talbert DR; Allred CD; Zaytseva YY; Kilgore MW
Breast Cancer Res Treat; 2008 Mar; 108(1):23-33. PubMed ID: 17453334
[TBL] [Abstract][Full Text] [Related]
35. Effects of exon-deleted estrogen receptor beta transcript variants on growth, apoptosis and gene expression of human breast cancer cell lines.
Treeck O; Juhasz-Boess I; Lattrich C; Horn F; Goerse R; Ortmann O
Breast Cancer Res Treat; 2008 Aug; 110(3):507-20. PubMed ID: 17876701
[TBL] [Abstract][Full Text] [Related]
36. Extraction-dependent effects of American ginseng (Panax quinquefolium) on human breast cancer cell proliferation and estrogen receptor activation.
King ML; Adler SR; Murphy LL
Integr Cancer Ther; 2006 Sep; 5(3):236-43. PubMed ID: 16880429
[TBL] [Abstract][Full Text] [Related]
37. Differential response of estrogen receptor subtypes to 1,3-diarylindene and 2,3-diarylindene ligands.
Clegg NJ; Paruthiyil S; Leitman DC; Scanlan TS
J Med Chem; 2005 Sep; 48(19):5989-6003. PubMed ID: 16162002
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, antiviral and antitumor activity of 2-substituted-5-amidino-benzimidazoles.
Starcević K; Kralj M; Ester K; Sabol I; Grce M; Pavelić K; Karminski-Zamola G
Bioorg Med Chem; 2007 Jul; 15(13):4419-26. PubMed ID: 17482821
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and cytotoxic evaluation of novel 2-(4-(2,2,2-trifluoroethoxy)-3-methylpyridin-2-ylthio)-1H-benzo[d]imidazole derivatives.
Ranganatha SR; Kavitha CV; Vinaya K; Prasanna DS; Chandrappa S; Raghavan SC; Rangappa KS
Arch Pharm Res; 2009 Oct; 32(10):1335-43. PubMed ID: 19898794
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, biochemical properties and molecular modelling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens and hydroxyferrocifens: evidence for an antiproliferative effect of hydroxyferrocifens on both hormone-dependent and hormone-independent breast cancer cell lines.
Top S; Vessières A; Leclercq G; Quivy J; Tang J; Vaissermann J; Huché M; Jaouen G
Chemistry; 2003 Nov; 9(21):5223-36. PubMed ID: 14613131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]